David W. Nassif Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David W. Nassif.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David W. Nassif. David W. Nassif is EVP and CFO in SteadyMed Ltd. ($STDY) and Chief Financial Officer in Sio Gene Therapies Inc. ($AXON) and Principal Financial Officer in Axovant Gene Therapies Ltd. ($AXON).
Latest Insider Trading Transactions of David W. Nassif
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Option Exercise | A | 2.47 | 239,000 | 590,330 | 239,000 | |
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Option Exercise | A | 2.47 | 239,000 | 590,330 | 239,000 | |
| Mar 22 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Option Exercise | D | 0.00 | 15,060 | 0 | 0 | |
| Mar 22 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Grant | A | 0.00 | 15,060 | 0 | 34,004 | 18.9 K to 34 K (+79.50 %) |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | D | 0.00 | 15,060 | 0 | 15,060 | |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Payment of Exercise | F | 3.25 | 5,266 | 17,115 | 18,944 | 24.2 K to 18.9 K (-21.75 %) |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Grant | A | 0.00 | 15,060 | 0 | 24,210 | 9.2 K to 24.2 K (+164.59 %) |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 0.00 | 52,600 | 0 | 52,600 | |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 3.45 | 78,900 | 272,205 | 78,900 | |
| Sep 24 2019 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 0.00 | 30,120 | 0 | 30,120 | |
| Jul 02 2019 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 6.42 | 75,000 | 481,500 | 75,000 | |
| Jul 02 2019 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 6.42 | 150,000 | 963,000 | 150,000 | |
| Sep 04 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | J | 3.65 | 15,987 | 58,353 | 0 | |
| Sep 04 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | J | 2.74 | 40,000 | 109,600 | 0 | |
| Sep 04 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | J | 5.84 | 51,832 | 302,699 | 0 | |
| Sep 04 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | J | 3.61 | 159,642 | 576,308 | 0 | |
| Sep 04 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | J | 3.61 | 3,100 | 11,191 | 0 | |
| Sep 04 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Sell | S | 4.46 | 22,157 | 98,820 | 0 | 22.2 K to 0 (-100.00 %) |
| Jul 09 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Sell | S | 4.50 | 12,157 | 54,707 | 22,157 | 34.3 K to 22.2 K (-35.43 %) |
| Jul 03 2018 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Sell | S | 4.50 | 10,001 | 45,005 | 34,314 | 44.3 K to 34.3 K (-22.57 %) |
| Dec 28 2017 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | A | 3.65 | 15,987 | 58,353 | 15,987 | |
| Nov 15 2017 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Grant | A | 0.00 | 44,315 | 0 | 44,315 | 0 to 44.3 K |
| Jul 22 2016 | STDY | SteadyMed Ltd. | Nassif David W. | EVP and CFO | Option Exercise | A | 2.74 | 40,000 | 109,600 | 40,000 |
Page: 1